Ana Sayfa
Piyasalar
Grafikler ve Fikirler
Algo
Haberler
Store
Aracı Kurumlar
İndir
Ekonomik Takvim
Alım-Satım Sinyalleri
Web Terminali
Heatmap
Arama yapmak için
/
tuşuna basın: @kullanıcı, $sembol, ...
Ara
Giriş yap
Hesap oluştur
Türkçe
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
MDGL
#810
Madrigal Pharmaceuticals, Inc. Common Stock
518.820
0
USD
-1.18%
Sektör:
Sağlık Hizmetleri
Baz:
USD
Kar Para Birimi:
USD
Günlük Aralık
Yıllık Aralık
Günlük Değişim
-1.18%
Aylık Değişim
+16.11%
6 aylık değişim
+22.48%
Yıllık Değişim
+22.48%
Önceki Kapanış
524.990
0
Open
515.020
0
Bid
Ask
Low
515.000
0
High
518.820
0
Hacim
47
Piyasalar
ABD Borsası
Sağlık Hizmetleri
MDGL
Open full chart
Financials
Overview
Rapor
Statistics
Quarterly
Annual
Value
Q4, 24
Q1, 25
Q2, 25
Q3, 25
Q4, 25
TTM
Key stats
Total common shares outstanding
22.08 M
22.2 M
22.29 M
22.71 M
22.94 M
—
Valuation ratios
Enterprise value
6.83 B
7.29 B
6.68 B
10.46 B
13.5 B
37.93 B
Price to earnings ratio
-14.09
-18.57
-23.94
-35.83
-45.32
-123.66
Price to sales ratio
36.44
22.67
12.87
13.72
13.63
62.89
Price to cash flow ratio
-14.41
-18.08
-21.41
-61.13
-68.92
-169.55
Price to book ratio
8.7
2.31
2.25
3.62
21.68
29.85
Enterprise value to EBITDA ratio
-13.75
-17.16
-21.59
-34.08
-45.24
-118.07
Profitability ratios
Return on assets %
-0.06
-0.07
-0.04
-0.08
-0.05
-0.25
Return on equity %
-0.08
-0.1
-0.06
-0.18
-0.1
-0.44
Return on invested capital %
-1 640.46
—
—
—
-974.02
—
Gross margin %
100
96.71
100
100
100
396.71
Operating margin %
-64.84
-57.79
-22.18
-39.68
-18.56
-138.21
EBITDA margin %
-61.16
-60.8
-22
-39.55
-18.44
-140.8
Net margin %
-57.51
-53.36
-19.87
-39.75
-18.24
-131.22
Liquidity ratios
Quick ratio
5.9
5.58
4.78
3.26
3.77
17.4
Current ratio
6.1
5.91
5.11
3.44
4.01
18.47
Inventory turnover
—
0.1
—
—
—
—
Asset turnover
0.1
0.13
0.21
0.24
0.24
0.83
Solvency ratios
Debt to assets ratio
0.11
0.12
0.12
0.25
0.27
0.75
Debt to equity ratio
0.16
0.17
0.17
0.54
0.56
1.44
Long term debt to total assets ratio
0.11
0.12
0.12
0.25
0.27
0.75
Long term debt to total equity ratio
0.16
0.17
0.17
0.54
0.56
1.44
Per share metrics
Operating cash flow per share
-4.91
-4.02
-2.12
3.55
-5.95
-8.54
EBIT per share
-2.99
-3.79
-2.13
-5.07
-2.66
-13.65
EBITDA per share
-2.97
-3.78
-2.11
-5.05
-2.64
-13.58
Total debt per share
5.53
5.34
5.33
15.11
15.15
40.93
Cash per share
43.78
38.39
36.12
49.58
43.84
167.93
Net current asset value per share
48.56
44.72
45.18
59.9
55.53
205.33
Tangible book value per share
35.24
31.96
31.14
27.5
26.54
117.13
Working capital per share
40.6
37.15
36.33
42.49
41.7
157.67
Book value per share
35.46
32.17
31.34
27.83
26.86
118.21
Haberler
Wolfe Research, Madrigal hissesi için Peerperform görüşünü korudu
United Therapeutics (UTHR) Up 5.7% Since Last Earnings Report: Can It Continue?
Madrigal (MDGL) Surges 12.3%: Is This an Indication of Further Gains?
Why Is Corcept (CORT) Up 11.7% Since Last Earnings Report?
ALT Stock and the 2026 MASH Race: Dual Agonists vs. New Mechanisms
ALT Pemvidutide Explained: What Makes It Different in MASH
Tracking John Paulson’s Paulson & Company Portfolio – Q4 2025 Update
Tracking Baker Brothers Portfolio – Q4 2025 Update (NASDAQ:INCY)
Madrigal Pharmaceuticals EVP Dier 854 bin dolarlık hisse sattı
Madrigal Pharmaceuticals EVP Dier sells $854k in stock
Madrigal Pharmaceuticals CEO’su Sibold 718 bin dolarlık hisse sattı
Madrigal Pharmaceuticals CEO Sibold sells $718k in shares